Holen Sie sich die Stockscreener-App
0.2918
10.24%
-0.0333
Handel nachbörslich:
.31
0.0182
+6.24%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$0.3251
Offen:
$0.323
24-Stunden-Volumen:
1.80M
Relative Volume:
0.29
Marktkapitalisierung:
$12.12M
Einnahmen:
$7.33M
Nettoeinkommen (Verlust:
$-21.20M
KGV:
-0.3192
EPS:
-0.9143
Netto-Cashflow:
$-12.68M
1W Leistung:
-24.31%
1M Leistung:
-47.86%
6M Leistung:
-11.76%
1J Leistung:
-86.68%
1-Tages-Spanne:
$0.2884
$0.323
1-Wochen-Bereich:
$0.2884
$0.4206
52-Wochen-Spanne:
$0.2179
$2.17
Prophase Labs Inc Stock (PRPH) Company Profile
Firmenname
Prophase Labs Inc
Sektor
Branche
Telefon
(215) 345-0919
Adresse
711 STEWART AVE, SUITE 200, NEW YORK, PA
Vergleichen Sie PRPH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRPH
Prophase Labs Inc
|
0.2918 | 13.51M | 7.33M | -21.20M | -12.68M | -0.9143 |
|
TMO
Thermo Fisher Scientific Inc
|
565.24 | 212.23B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
213.83 | 151.20B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
722.12 | 57.84B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
146.08 | 41.02B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
210.96 | 36.42B | 15.90B | 1.28B | 2.21B | 7.2842 |
Prophase Labs Inc Stock (PRPH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-12-20 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-10-13 | Herabstufung | Dawson James | Buy → Neutral |
| 2021-01-20 | Eingeleitet | Dawson James | Buy |
Prophase Labs Inc Aktie (PRPH) Neueste Nachrichten
How ProPhase Labs Inc. stock reacts to job market data2025 Technical Overview & Real-Time Stock Movement Alerts - newser.com
Using data filters to optimize entry into ProPhase Labs Inc.Trade Risk Report & Community Consensus Stock Picks - newser.com
How hedge fund analytics apply to ProPhase Labs Inc. stockEarnings Miss & Low Drawdown Trading Techniques - newser.com
Can machine learning forecast ProPhase Labs Inc. recoveryJuly 2025 Big Picture & Safe Entry Point Identification - newser.com
What moving averages say about ProPhase Labs Inc.CEO Change & AI Driven Price Predictions - newser.com
Is ProPhase Labs Inc. stock poised for growth2025 Major Catalysts & High Conviction Trade Alerts - newser.com
ProPhase Labs Inc. stock chart pattern explainedWeekly Profit Analysis & High Yield Stock Recommendations - newser.com
Why analysts upgrade ProPhase Labs Inc. stockGDP Growth & Step-by-Step Trade Execution Guides - newser.com
Using data tools to time your ProPhase Labs Inc. exit2025 Market Sentiment & Expert Verified Movement Alerts - newser.com
What data driven models say about ProPhase Labs Inc.’s futurePortfolio Performance Summary & Weekly Market Pulse Alerts - newser.com
ProPhase Labs Inc. stock retracement – recovery analysisTrade Risk Summary & Long-Term Capital Growth Ideas - newser.com
Can ProPhase Labs Inc. stock beat analyst upgradesMarket Risk Analysis & Fast Moving Trade Plans - newser.com
How strong is ProPhase Labs Inc. stock revenue growth2025 Major Catalysts & High Accuracy Trade Alerts - newser.com
PRPH proxy: digital‑asset charter, tokenized equity cap, split range - Stock Titan
Is ProPhase Labs Inc. building a consolidation baseWeekly Risk Summary & High Accuracy Buy Signal Tips - newser.com
ProPhase Labs Announces Publication of BE-Smart Esophageal Cancer Study in the Official Journal of the American College of Gastroenterology - The Manila Times
ProPhase (NASDAQ: PRPH) BE-Smart study shows 100% sensitivity; AUC 0.89 - Stock Titan
ProPhase Labs hires former Barstool Sports COO Stuart Hollenshead, plans cost-cutting measures - MSN
What technical signals suggest for ProPhase Labs Inc. stockJuly 2025 Price Swings & Safe Capital Investment Plans - fcp.pa.gov.br
ProPhase Labs Engages RedChip Companies to Lead Investor Relations Efforts - The Manila Times
ProPhase Labs (NASDAQ: PRPH) engages RedChip to lead investor relations: $50M target - Stock Titan
How ProPhase Labs Inc. stock reacts to inflationary pressures2025 Top Decliners & Low Risk Profit Maximizing Plans - Fundação Cultural do Pará
Finanzdaten der Prophase Labs Inc-Aktie (PRPH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
6.29%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):